Enabling rapid responses to infectious diseases.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Abstract:
      The COVID-19 pandemic has been met with an unparalleled response by the global scientific community and its stakeholders, who have developed vaccines and therapeutic antibodies in an unprecedented timescale. However, while mRNA vaccines contain the RNA genetic code for a single antigen, saRNA vaccines comprise the RNA of their target antigen and four additional alphavirus proteins that form the RNA-dependent replicase. ASTRAZENECA'S ONGOING COMMITMENT TO VACCINES AND IMMUNE THERAPIES AstraZeneca supports broad and equitable vaccine access. [Extracted from the article]
    • Abstract:
      Copyright of Scientific American is the property of Scientific American and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)